| Literature DB >> 34221250 |
Depeng Rao1, Kainan Mei1, Tianhao Yan1, Yu Wang1, Wenjie Wu1, Ye Chen1, Jianye Wang2, Qingchuan Zhang1, Shangquan Wu1.
Abstract
Early cancer diagnosis requires ultrasensitive detection of tumor markers in blood. To this end, we develop a novel microcantilever immunosensor using nanobodies (Nbs) as receptors. As the smallest antibody (Ab) entity comprising an intact antigen-binding site, Nbs achieve dense receptor layers and short distances between antigen-binding regions and sensor surfaces, which significantly elevate the generation and transmission of surface stress. Owing to the inherent thiol group at the C-terminus, Nbs are covalently immobilized on microcantilever surfaces in directed orientation via one-step reaction, which further enhances the stress generation. For microcantilever-based nanomechanical sensor, these advantages dramatically increase the sensor sensitivity. Thus, Nb-functionalized microcantilevers can detect picomolar concentrations of tumor markers with three orders of magnitude higher sensitivity, when compared with conventional Ab-functionalized microcantilevers. This proof-of-concept study demonstrates an ultrasensitive, label-free, rapid, and low-cost method for tumor marker detection. Moreover, interestingly, we find Nb inactivation on sensor interfaces when using macromolecule blocking reagents. The adsorption-induced inactivation is presumably caused by the change of interfacial properties, due to binding site occlusion upon complex coimmobilization formations. Our findings are generalized to any coimmobilization methodology for Nbs and, thus, for the construction of high-performance immuno-surfaces. Electronic Supplementary Material: Supplementary material (experimental section, HER2 detection using anti-HER2-mAb-functionalized microcantilevers) is available in the online version of this article at 10.1007/s12274-021-3588-4. © Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature 2021.Entities:
Keywords: adsorption-induced inactivation; early cancer detection; nanobody-based biosensor; stress enhancement; tumor markers
Year: 2021 PMID: 34221250 PMCID: PMC8240779 DOI: 10.1007/s12274-021-3588-4
Source DB: PubMed Journal: Nano Res ISSN: 1998-0000 Impact factor: 8.897